Search
for
Sort by
Research 631–660 of 1000+
- Insulin Promotes Corneal Nerve Repair and Wound Healing in Type 1 Diabetic Mice by Enhancing Wnt/β-Catenin Signaling
- Selection signatures of wool color in Gangba sheep revealed by genome-wide SNP discovery
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Differential Auxin-Transporting Activities of PIN-FORMED Proteins in Arabidopsis Root Hair Cells
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Phospholipase A2 Is Required for PIN-FORMED Protein Trafficking to the Plasma Membrane in the<i>Arabidopsis</i>Root
- Safety of dermatologic medications in pregnancy and lactation
- Polycystic ovary syndrome (PCOS)
- Ruxolitinib for the treatment of severe alopecia areata
- Central centrifugal cicatricial alopecia: challenges and solutions
- Treatment options for alopecia: an update, looking to the future
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Hidradenitis Suppurativa
- A Case of Cicatricial Alopecia Associated with Erlotinib
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus
- Deciphering principles of morphogenesis from temporal and spatial patterns on the integument
- Dermatologic Reactions to Targeted Therapy
- 1H NMR-based lipidomics of rodent fur: species-specific lipid profiles and SCD1 inhibitor-related dermal toxicity
- Cepharanthine inhibits enterovirus entry by endolysosomal deacidification and exhibits protective activity <i>in vivo</i>
- Off-label dermatologic uses of IL-23 inhibitors
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- The clinical applications of five-alpha reductase inhibitors.
- Dermatologic Adverse Events from Cancer Treatments
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- Steroid sulfatase inhibitors
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment